Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine A

Clinical Nephrology

Volumn 84, Issue 3, 2015, Pages 165-172

  Sommerer, Claudia ^a   Zeier, Martin ^a   Meuer, Stefan ^a   Giese, Thomas ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cyclosporine A; Gene expression; Immunosuppression; Monitoring; NFAT; Pharmacodynamics; Renal transplantation

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; TRANSCRIPTION FACTOR NFAT; CALCINEURIN INHIBITOR; CYCLOSPORIN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MONITORING; FEMALE; FOLLOW UP; GENE CONTROL; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; STEROID THERAPY; GENETICS; KIDNEY TRANSPLANTATION; METABOLISM; MIDDLE AGED;

ADULT; CALCINEURIN INHIBITORS; COHORT STUDIES; CYCLOSPORINE; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NFATC TRANSCRIPTION FACTORS;

EID: 84944040427     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108623     Document Type: Article

References (18)

1. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med. 2003; 349: 2326-2333. CrossRef PubMed
2. de Jonge H, Naesens M, Kuypers DR. New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation. Ther Drug Monit. 2009; 31: 416-435. CrossRef PubMed
3. Fukudo M, Yano I, Katsura T, Ito N, Yamamoto S, Kamoto T, Ogawa O, Inui K. A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection. Drug Metab Pharmacokinet. 2010; 25: 411-417. CrossRef PubMed
4. Couzi L, Thiébaut R, Carron JC, Moreau JF, Merville P, Taupin JL. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. Transplantation. 2008; 86: 1060-1067. CrossRef PubMed
5. Giese T, Zeier M, Schemmer P, Uhl W, Schoels M, Dengler T, Buechler M, Meuer S. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A. Transplantation. 2004; 77: 339-344. CrossRef PubMed
6. Sommerer C, Meuer S, Zeier M, Giese T. Calcineurin inhibitors and NFAT-regulated gene expression. Clin Chim Acta. 2012; 413: 1379-1386. CrossRef PubMed
7. Sommerer C, Konstandin M, Dengler T, Schmidt J, Meuer S, Zeier M, Giese T. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies. Transplantation. 2006; 82: 1280-1285. CrossRef PubMed
8. Zahn A, Schott N, Hinz U, Stremmel W, Schmidt J, Ganten T, Gotthardt D, Meuer S, Zeier M, Giese T, Sommerer C. Immunomonitoring of nuclear factor of activated T cells-regulated gene expression: the first clinical trial in liver allograft recipients. Liver Transpl. 2011; 17: 466-473. CrossRef PubMed
9. Konstandin MH, Sommerer C, Doesch A, Zeier M, Meuer SC, Katus HA, Dengler TJ, Giese T. Pharmacodynamic cyclosporine A-monitoring: relation of gene expression in lymphocytes to cyclosporine blood levels in cardiac allograft recipients. Transpl Int. 2007; 20: 1036-1043. CrossRef PubMed
10. Billing H, Giese T, Sommerer C, Zeier M, Feneberg R, Meuer S, TönshoffB. Pharmacodynamic monitoring of cyclosporine A by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients. Pediatr Transplant. 2010; 14: 844-851. CrossRef PubMed
11. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, BanfiG, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, et al. Banff07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008; 8: 753-760. CrossRef PubMed
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999; 130: 461-470. CrossRef PubMed
13. Wieland E, Olbricht CJ, Süsal C, Gurragchaa P, Böhler T, Israeli M, Sommerer C, Budde K, Hartmann B, Shipkova M, Oellerich M. Biomarkers as a tool for management of immunosuppression in transplant patients. Ther Drug Monit. 2010; 32: 560-572. CrossRef PubMed
14. Sommerer C, Hartschuh W, Enk A, Meuer S, Zeier M, Giese T. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients. Clin Transplant. 2008; 22: 549-554. CrossRef PubMed
15. Steinebrunner N, Sandig C, Sommerer C, Hinz U, Giese T, Stremmel W, Zahn A. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study. Ann Transplant. 2014; 19: 32-40. CrossRef PubMed
16. Steinebrunner N, Sandig C, Sommerer C, Hinz U, Giese T, Stremmel W, Zahn A. Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation. Transpl Infect Dis. 2014; 16: 379-386. CrossRef PubMed
17. Herden U, Kromminga A, Hagel C, Hartleb J, Nashan B, Sterneck M, Fischer L. Monitoring of nuclear factor of activated T-cell-regulated gene expression in de novo and long-term liver transplant recipients treated with cyclosporine a. Ther Drug Monit. 2011; 33: 185-191. PubMed
18. Sommerer C, Giese T, Schmidt J, Meuer S, Zeier M. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression. Transplantation. 2008; 85: 15-21. CrossRef PubMed